These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23549034)

  • 21. Institutional review boards and multisite studies in health services research: is there a better way?
    Gold JL; Dewa CS
    Health Serv Res; 2005 Feb; 40(1):291-307. PubMed ID: 15663714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Institutional review board variability in minimal-risk multicenter urogynecology studies.
    Harvie HS; Lowenstein L; Omotosho TB; Sanses T; Molden S; Hardy J; Brubaker L;
    Female Pelvic Med Reconstr Surg; 2012; 18(2):89-92. PubMed ID: 22453318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of the institutional review board process within a national research network.
    Khan MA; Barratt MS; Krugman SD; Serwint JR; Dumont-Driscoll M;
    Clin Pediatr (Phila); 2014 Jun; 53(6):556-60. PubMed ID: 24658908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical trials with minors in Germany--effects of the 12th amendment to the German Drug Code on the numbers of applications to Institutional Review Boards (IRB)].
    Kölch M; Märsch C; Fegert JM; Lippert HD
    Gesundheitswesen; 2009 Mar; 71(3):127-33. PubMed ID: 19221985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research ethics board approval for an international thromboprophylaxis trial.
    Lutz K; Wilton K; Zytaruk N; Julien L; Hall R; Harvey J; Skrobik Y; Vlahakis N; Meade L; Matte A; Meade M; Burns K; Albert M; Cash BB; Vallance S; Klinger J; Heels-Ansdell D; Cook D;
    J Crit Care; 2012 Jun; 27(3):225-31. PubMed ID: 22305662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rejuvenating a foundering institutional review board: one institution's story.
    De Ville K; Hassler G; Lewis MJ
    Acad Med; 2007 Jan; 82(1):11-7. PubMed ID: 17198283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problematic variation in local institutional review of a multicenter genetic epidemiology study.
    McWilliams R; Hoover-Fong J; Hamosh A; Beck S; Beaty T; Cutting G
    JAMA; 2003 Jul; 290(3):360-6. PubMed ID: 12865377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notes from the field: jumpstarting the IRB approval process in multicenter studies.
    Blustein J; Regenstein M; Siegel B; Billings J
    Health Serv Res; 2007 Aug; 42(4):1773-82. PubMed ID: 17610447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concept paper: a virtual centralized IRB system.
    McWilliams R; Hebden CW; Gilpin AM
    Account Res; 2006; 13(1):25-45. PubMed ID: 16770858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Knopman D; Alford E; Tate K; Long M; Khachaturian AS
    Alzheimers Dement; 2017 Aug; 13(8):940-946. PubMed ID: 28709585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to face the ethical challenges of multicentric clinical investigation?].
    Martínez SM
    Medicina (B Aires); 2008; 68(4):345-6. PubMed ID: 18786895
    [No Abstract]   [Full Text] [Related]  

  • 32. Alternatives to local institutional review board (IRB) system debated.
    Maloney DM
    Hum Res Rep; 2006 Apr; 21(4):1-2. PubMed ID: 16832918
    [No Abstract]   [Full Text] [Related]  

  • 33. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 34. New guidance on reviews by central institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2005 May; 20(5):1-2. PubMed ID: 16175714
    [No Abstract]   [Full Text] [Related]  

  • 35. Reforming the oversight of multi-site clinical research: a review of two possible solutions.
    Nowak KS; Bankert EA; Nelson RM
    Account Res; 2006; 13(1):11-24. PubMed ID: 16770857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical decision making in committee. A view from Germany.
    Sass HM
    Not Polit; 2002; 18(67):65-81. PubMed ID: 15282922
    [No Abstract]   [Full Text] [Related]  

  • 38. Variation in local institutional review board evaluations of a multicenter patient safety study.
    Thompson DA; Kass N; Holzmueller C; Marsteller JA; Martinez EA; Gurses AP; Kanchuger M; Schwann N; Gibson CS; Bauer L; Pronovost PJ
    J Healthc Qual; 2012; 34(4):33-9. PubMed ID: 22060010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A central institutional review board for multi-institutional trials.
    Christian MC; Goldberg JL; Killen J; Abrams JS; McCabe MS; Mauer JK; Wittes RE
    N Engl J Med; 2002 May; 346(18):1405-8. PubMed ID: 11986418
    [No Abstract]   [Full Text] [Related]  

  • 40. Breaking the camel's back: multicenter clinical trials and local institutional review boards.
    Burman WJ; Reves RR; Cohn DL; Schooley RT
    Ann Intern Med; 2001 Jan; 134(2):152-7. PubMed ID: 11177319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.